STATEMENTS OF CASH FLOWS (USD $)	9 Months Ended		56 Months Ended
	Sep. 30, 2011	Sep. 30, 2010	Sep. 30, 2011
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (1,174,841)	$ (811,751)	$ (4,550,640)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation	24,374	24,374	127,289
Allowance for uncollectible notes receivable	13,867	0	38,867
Amortization of deferred finance costs	1,252	29,760	33,492
Interest income (expense) on fair value adjustments on convertible notes payable	(18,279)	65,096	170,370
Interest accrued on note receivable	0	0	(11,705)
Write off of uncollectible deposit	0	0	20,000
Loss on extinguishment of debt	277,489	41,500	323,609
Loss on impairment	21,000		21,000
Stock issued for services	317,169	303,031	1,463,862
Changes in operating assets and liabilities:
Deposits and other receivables	(48,702)	(1,717)	(72,048)
Accounts payable and accrued liabilities	184,173	(27,361)	394,880
Net cash used in operating activities	(402,498)	(377,068)	(2,041,024)
CASH FLOWS FROM INVESTING ACTIVITIES:
Payments of notes receivable	0	0	(25,000)
Purchase of securities	(21,000)	(1,100)	(22,100)
Acquisition of equipment	0	0	(325,000)
Net cash used in investing activities	(21,000)	(1,100)	(372,100)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from issuance of common stock	272,670	218,196	1,764,642
Proceeds from the issuance of convertible notes, related parties	0	6,000	6,000
Proceeds from the issuance of convertible notes, non related parties	20,000	152,500	438,300
Proceeds from the issuance of notes payable	155,000	47,500	271,500
Proceeds from the issuance of notes payable, related parties	5,000	0	5,000
Payments on convertible notes payable	(25,000)	0	(35,000)
Payments on notes payable	0	0	(40,000)
Proceeds from loans from stockholders	0	0	35,925
Payments on loans from stockholders	(5,225)	(26,000)	(31,225)
Net cash provided by financing activities	422,445	398,196	2,415,142
NET INCREASE IN CASH	(1,053)	20,028	2,018
CASH, BEGINNING OF PERIOD	3,071	1,015	0
CASH, END OF PERIOD	2,018	21,043	2,018
NONCASH FINANCING ACTIVITIES:
Due to Organetix, Inc. reclassified to additional paid-in capital	0	0	91,500
Common stock issued for loan financing fees	1,250	5,000	6,250
Common stock issued to satisfy minimum value guarantee	0	0	87,667
Common stock issued to satisfy payment for legal services	40,559	0	40,559
Shares issued for consulting services	397,128	285,320	1,543,821
Convertible debt converted to common stock including accrued interest	499,910	217,962	937,648
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:
Interest	$ 0	$ 0	$ 3,660